TMPRSS2 and COVID-19: Therefore, an increased understanding of the functions and interactions of TMPRSS2 with the JAK-STAT pathway and their regulated molecules, such as class I human leukocyte antigens (HLA-I) and PD-L1, is urgently needed and might provide insights into their potential as therapeutic targets thereby enhancing the patients’ outcomes by improving the management of COVID-19.